Global Sterility Testing Market Size, Trends, and Growth Opportunity, By Product Type (Instruments, Kits and Reagents, and Services), By Test Type (Membrane Filtration, Direct Inoculation, and Other Sterility Tests), By Application (Pharmaceutical and Biological Manufacturing, Medical Devices Manufacturing, and Other Applications), Regional Outlook, Competitive Market Share & Forecast, 2022 – 2027.
Report ID : IR1001440 | Industries : Healthcare | Published On :June 2024 | Page Count : 242
Global Sterility Testing Market Size, Trends, and Growth Opportunity, By Product Type (Instruments, Kits and Reagents, and Services), By Test Type (Membrane Filtration, Direct Inoculation, and Other Sterility Tests), By Application (Pharmaceutical and Biological Manufacturing, Medical Devices Manufacturing, and Other Applications), Regional Outlook, Competitive Market Share & Forecast, 2022 – 2027.
Global Sterility Testing Market
The global Sterility Testing Market was valued at USD 1,300 million in 2021 and is expected to reach USD 2,500 million by 2027, at a CAGR of 9.13% from 2022-2027.
Sterility testing is designed to demonstrate the presence & absence of extraneous viable contaminating microorganisms in biological parenteral designed for human use. There are 3 methods of Sterility Testing: Membrane Filtration, Direct Transfer, and Product Flush. Sterility can be divided into 3 subtypes: natural, clinical, and hardship.
Market Drivers
The rising burden of infectious and chronic diseases among patients increases the demand for strict sterility testing of drugs and medical devices to ensure the safety of the devices. This is expected to fuel the market growth over the forecast period of 2027.
Furthermore, government initiatives and investments in the healthcare sector, rising R&D activities, a surge in the number of drug launches, and an increasing focus on quality and sterility are the factors expected to drive the sterility testing market in the future.
Market Restraints
A rising sterility testing unit price and the scarcity of qualified sterility test professionals due to strict government regulations will highly obstruct market growth.
Also, high levels of consolidation, and rigid regulatory frameworks & lengthy licensing processes, are some of the significant barriers to new market entrants.
Market Segmentation
The global sterility testing market is segmented into product type, test type, application, and region.
Based on product type, the sterility testing market is segmented into instruments, kits and reagents, and services. Further, based on application, the market is segmented into pharmaceutical & biological manufacturing, medical devices manufacturing, and other applications.
Regional Analysis
The global sterility testing market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
The North American region is expected to dominate the sterility testing market, mainly because of the growing research & innovations in the biotechnology & pharmaceutical industries in the region, the increasing investments in R&D activities in life sciences & medical technology, and government initiatives.
The Asia Pacific region is anticipated to witness the fastest growth during the forecast period of 2027. This can be attributed to the rising harmonization of the regulatory standards with the ICH standards in developing nations.
Key Players
Various key players are discussed in the global sterility testing market report including: Merck KGaA, Baxter Healthcare Corporation, Boston Analytical, Neopharm Labs Inc., LexaMed LTD, Danaher Corporation, Sartorius AG, Gibraltar Laboratories, Pace Analytical Services, Inc., Sigma-Aldrich Co. LLC., and Others.
For instance, in March 2022, VBI Vaccines Inc. launched PreHevbrioin in the U.S. for the prevention of infection caused by all known subtypes of hepatitis B virus in adults of age 18 years & older. This vaccine was approved by the FDA of the U.S. as the only approved 3-antigen HBV vaccine for adults in the year 2021.
Market Taxonomy
By Product Type
• Instruments
• Kits and Reagents
• Services
By Test Type
• Membrane Filtration
• Direct Inoculation
• Other Sterility Tests
By Application
• Pharmaceutical and Biological Manufacturing
• Medical Device Manufacturing
• Other Applications
By Region
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa
Global Sterility Testing Market
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Sterility Testing Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Sterility Testing Market, By Product Type
5.1 Y-o-Y Growth Comparison, By Product Type
5.2 Global Sterility Testing Market Share Analysis, By Product Type
5.3 Global Sterility Testing Market Size and Forecast, By Product Type
5.3.1 Instruments
5.3.2 Kits and Reagents
5.3.3 Services
6 Global Sterility Testing Market, By Test Type
6.1 Y-o-Y Growth Comparison, By Test Type
6.2 Global Sterility Testing Market Share Analysis, By Test Type
6.3 Global Sterility Testing Market Size and Forecast, By Test Type
6.3.1 Membrane Filtration
6.3.2 Direct Inoculation
6.3.3 Other Sterility Tests
7 Global Sterility Testing Market, By Application
7.1 Y-o-Y Growth Comparison, By Application
7.2 Global Sterility Testing Market Share Analysis, By Application
7.3 Global Sterility Testing Market Size and Forecast, By Application
7.3.1 Pharmaceutical and Biological Manufacturing
7.3.2 Medical Device Manufacturing
7.3.3 Other Applications
8 Global Sterility Testing Market, By Region
8.1 Global Sterility Testing Market Share Analysis, By Region
8.2 Global Sterility Testing Market Share Analysis, By Region
8.3 Global Sterility Testing Market Size and Forecast, By Region
9 North America Sterility Testing Market Analysis and Forecast (2022-2027)
9.1 Introduction
9.2 North America Sterility Testing Market Share Analysis, By Product Type
9.3 North America Sterility Testing Market Share Analysis, By Test Type
9.4 North America Sterility Testing Market Size and Forecast, By Application
9.5 North America Sterility Testing Market Size and Forecast, By Country
9.5.1 U.S.
9.5.2 Canada
9.5.3 Mexico
10 Europe Sterility Testing Market Analysis and Forecast (2022-2027)
10.1 Introduction
10.2 Europe Sterility Testing Market Share Analysis, By Product Type
10.3 Europe Sterility Testing Market Share Analysis, By Test Type
10.4 Europe Sterility Testing Market Size and Forecast, By Application
10.5 Europe Sterility Testing Market Size and Forecast, By Country
10.5.1 Germany
10.5.2 France
10.5.3 UK
10.5.4 Rest of Europe
11 Asia Pacific Sterility Testing Market Analysis and Forecast (2022-2027)
11.1 Introduction
11.2 Asia Pacific Sterility Testing Market Share Analysis, By Product Type
11.3 Asia Pacific Sterility Testing Market Share Analysis, By Test Type
11.4 Asia Pacific Sterility Testing Market Size and Forecast, By Application
11.5 Asia Pacific Sterility Testing Market Size and Forecast, By Country
11.5.1 China
11.5.2 Japan
11.5.3 India
11.5.4 Rest of Asia Pacific
12 Latin America Sterility Testing Market Analysis and Forecast (2022-2027)
12.1 Introduction
12.2 Latin America Sterility Testing Market Share Analysis, By Product Type
12.3 Latin America Sterility Testing Market Share Analysis, By Test Type
12.4 Latin America Sterility Testing Market Size and Forecast, By Application
12.5 Latin America Sterility Testing Market Size and Forecast, Country
12.5.1 Brazil
12.5.2 Rest of Latin America
13 Middle East Sterility Testing Market Analysis and Forecast (2022-2027)
13.1 Introduction
13.2 Middle East Sterility Testing Market Share Analysis, By Product Type
13.3 Middle East Sterility Testing Market Share Analysis, By Test Type
13.4 Middle East Sterility Testing Market Size and Forecast, By Application
13.5 Middle East Sterility Testing Market Size and Forecast, By Country
13.5.1 Saudi Arabia
13.5.2 UAE
13.5.3 Egypt
13.5.4 Kuwait
13.5.5 South Africa
14 Competitive Analysis
14.1 Competition Dashboard
14.2 Market share Analysis of Top Vendors
14.3 Key Development Strategies
15 Company Profiles
15.1 Merck KGaA
15.1.1 Overview
15.1.2 Offerings
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2 Baxter Healthcare Corporation
15.2.1 Overview
15.2.2 Offerings
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.25 Key Market Developments
15.2.6 Key Strategies
15.3 Boston Analytical
15.3.1 Overview
15.3.2 Offerings
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 Neopharm Labs Inc.
15.4.1 Overview
15.4.2 Offerings
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 LexaMed LTD
15.5.1 Overview
15.5.2 Offerings
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6 Danaher Corporation
15.6.1 Overview
15.6.2 Offerings
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
15.7 Sartorius AG
15.7.1 Overview
15.7.2 Offerings
15.7.3 Key Financials
15.7.4 Business Segment & Geographic Overview
15.7.5 Key Market Developments
15.7.6 Key Strategies
15.8 Gibraltar Laboratories
15. 8.1 Overview
15.8.2 Offerings
15.8.3 Key Financials
15.8.4 Business Segment & Geographic Overview
15.8.5 Key Market Developments
15.8.6 Key Strategies
15.9 Pace Analytical Services, Inc.
15.9.1 Overview
15.9.2 Offerings
15.4.9.3 Key Financials
15.9.4 Business Segment & Geographic Overview
15.9.5 Key Market Developments
15.9.6 Key Strategies
15.10 Sigma-Aldrich Co. LLC.
15.10.1 Overview
15.10.2 Offerings
15.10.3 Key Financials
15.10.4 Business Segment & Geographic Overview
15.10.5 Key Market Developments
15.10.6 Key Strategies
